Version 2.77

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
49083-9 North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel
Indent46446-1 Record ID section Set NAACCR v.11
IndentIndent21827-1 Transmitted record type NAACCR message
IndentIndent42023-2 NAACCR facility identification system coding system
IndentIndent21830-5 Version NAACCR message
IndentIndent21829-7 Institution data source Registry message
IndentIndent21831-3 Unique tumor case ID Cancer
IndentIndent42022-4 NAACCR hospital tumor registration.permanent [Identifier]
Indent46439-6 Demographic section Set NAACCR v.11
IndentIndent21832-1 Coding system 1970/80/90 Census tract at cancer diagnosis
IndentIndent21833-9 Alternate census tract at cancer diagnosis
IndentIndent21851-1 Address at cancer diagnosis
IndentIndent21852-9 Census tract certainty 1970and80and90
IndentIndent42026-5 Census tract certainty 2000
IndentIndent21835-4 Coding system.current Race
IndentIndent21836-2 Coding system.original Race
IndentIndent21837-0 Hispanic origin Best estimate
IndentIndent21838-8 Ethnicity Computed
IndentIndent21839-6 Derivation method Computed Ethnicity
IndentIndent21840-4 Sex [NAACCR v.11]
IndentIndent21841-2 Age at cancer diagnosis a
IndentIndent21842-0 Birthplace
IndentIndent21843-8 History of Usual occupation
IndentIndent21844-6 History of Usual industry
IndentIndent21845-3 Source of information Usual occupational Hx
IndentIndent21846-1 Source of information Usual industry Hx
IndentIndent21847-9 Usual occupation Narrative
IndentIndent21848-7 Usual industry Narrative
IndentIndent21849-5 Coding system Occupational and Industry Hx
IndentIndent21850-3 Family history of Cancer Narrative
IndentIndent39810-7 RuralUrban continuum 1993
IndentIndent42125-5 RuralUrban continuum 2000
IndentIndent42024-0 NAACCR hispanic identification algorithm hispanic origin Derived
IndentIndent42025-7 NAACCR Indian Health Service linkage
IndentIndent53720-9 Race NAPIIA
IndentIndent42027-3 Geographic information system coordinate quality Cancer
IndentIndent49084-7 Census block group 1970and80and90
Indent46438-8 Cancer identification section Set NAACCR v.11
IndentIndent21853-7 Sequence number central.patient Cancer
IndentIndent21854-5 Date first Dx Cancer
IndentIndent21855-2 Primary site Cancer
IndentIndent21856-0 Histology ICD-O-2 Cancer
IndentIndent21857-8 Behavior ICD-O-2 Cancer
IndentIndent31205-8 Histology ICD-O-3 Cancer
IndentIndent31206-6 Behavior ICD-O-3 Cancer
IndentIndent21858-6 Grade Cancer
IndentIndent42129-7 Site coding system.current Cancer site
IndentIndent21859-4 Coding system.original Cancer site
IndentIndent42034-9 Coding system.current Cancer morphology
IndentIndent21860-2 Coding system.original Cancer morphology
IndentIndent21861-0 Dx confirmed by Cancer
IndentIndent21862-8 Source of document used to abstract Cancer
IndentIndent21863-6 Date last screened Cancer
IndentIndent21864-4 Most recent screening result for Cancer
IndentIndent42035-6 Casefinding source Cancer
IndentIndent42028-1 NAACCR ambiguous terminology as basis for diagnosis
IndentIndent42029-9 Date of conclusive diagnosis Cancer
IndentIndent42030-7 Multiple tumors reported as single primary Cancer
IndentIndent42031-5 Date of diagnosis of multiple tumors Cancer
IndentIndent42032-3 Number of tumors at diagnosis Cancer {#}
IndentIndent42033-1 Number of tumors and histologies {#}
Indent46443-8 Hospital-specific section Set NAACCR v.11
IndentIndent21865-1 Hospital.reporting [Identifier] Cancer
IndentIndent42106-5 Archive facility identification number Cancer
IndentIndent21866-9 Patient
IndentIndent21867-7 Sequence Cancer
IndentIndent21868-5 User assigned Abstractor
IndentIndent21869-3 Hospital admission.first contact [Date and time] Cancer
IndentIndent21870-1 Date of inpatient admission Cancer
IndentIndent21871-9 Date of inpatient discharge Cancer
IndentIndent21872-7 Relationship between this hospital and cancer Dx
IndentIndent21873-5 Year first seen at this hospital for [Date] Cancer {yyyy}
IndentIndent21874-3 Cancer conference.presentation status at reporting facility
IndentIndent21875-0 Cancer conference [Date and time]
IndentIndent21876-8 Surgery procedure for primary site at facility.YYY Cancer
IndentIndent21877-6 Surgery procedure for regional nodes at facility.YYY Cancer
IndentIndent21878-4 Other regional disease at facility.YYY most definitive procedure Cancer
IndentIndent21879-2 Surgery.regional nodes examined at facility.YYY most definitive procedure [#] Surgery Cancer
IndentIndent21880-0 Radiation treatment therapy Cancer
IndentIndent21881-8 Chemotherapy treatment at facility.YYY Cancer
IndentIndent21882-6 Hormone treatment at facility.YYY Cancer
IndentIndent21883-4 Transplant treatment at facility.YYY Cancer
IndentIndent21884-2 Other treatment at facility.YYY Cancer
IndentIndent21885-9 Surgery.not cancer treatment at facility.YYY
IndentIndent42124-8 Palliative procedure at this facility Cancer
Indent46448-7 Stage/prognostic factors section Set NAACCR v.11
IndentIndent39806-5 Summary stage at Dx 2000 revised Cancer
IndentIndent21887-5 SEER summary stage 1977 Cancer
IndentIndent21888-3 Summary stage abbreviated at Dx Cancer
IndentIndent21889-1 Size Tumor mm
IndentIndent21890-9 Extension Cancer
IndentIndent21891-7 Extent of disease Prostate cancer
IndentIndent21892-5 Lymph node involvement Cancer
IndentIndent21893-3 Regional lymph nodes positive [#] Specimen {#}
IndentIndent21894-1 Regional lymph nodes examined [#] Specimen {#}
IndentIndent21895-8 Extent of disease.NAACCR.old 13 digit
IndentIndent21896-6 Extent of disease.NAACCR.old 2 digit
IndentIndent21897-4 Extent of disease.NAACCR.old 4 digit
IndentIndent21898-2 Version used Extent of disease coding system
IndentIndent21899-0 Primary tumor.pathology Cancer
IndentIndent21900-6 Regional lymph nodes.pathology [Class] Cancer
IndentIndent21901-4 Distant metastases.pathology [Class] Cancer
IndentIndent21902-2 Stage group.pathology Cancer
IndentIndent21903-0 Descriptor.pathology Cancer Narrative
IndentIndent21904-8 Stager.pathology Cancer
IndentIndent21905-5 Primary tumor.clinical [Class] Cancer
IndentIndent21906-3 Regional lymph nodes.clinical [Class] Cancer
IndentIndent21907-1 Distant metastases.clinical [Class] Cancer
IndentIndent21908-9 Stage group.clinical Cancer
IndentIndent21909-7 Descriptor.clinical Cancer Narrative
IndentIndent21910-5 Stager.clinical Cancer
IndentIndent21917-0 Version used [Identifier] TNM classification
IndentIndent21919-6 Date 1st positive Bx Cancer
IndentIndent21920-4 Site of distant metastasis Cancer
IndentIndent21921-2 Pediatric stage Cancer
IndentIndent21922-0 Coding system used Cancer pediatric staging
IndentIndent21923-8 Pediatric cancer stager
IndentIndent21924-6 Tumor marker Cancer
IndentIndent42079-4 Tumor size.collaborative staging mm;cm
IndentIndent42080-2 Extension collaborative staging Cancer
IndentIndent42081-0 Collaborative staging tumor size extension evaluation Cancer
IndentIndent42082-8 Collaborative staging lymph nodes Cancer
IndentIndent42083-6 Collaborative staging regional nodes evaluation Cancer
IndentIndent42084-4 Collaborative staging metastasis at diagnosis Cancer
IndentIndent42085-1 Collaborative staging metastasis evaluation Cancer
IndentIndent42086-9 Collaborative staging site-Specific factor 1 Cancer
IndentIndent42087-7 Collaborative staging site-Specific factor 2 Cancer
IndentIndent42088-5 Collaborative staging site-Specific factor 3 Cancer
IndentIndent42089-3 Collaborative staging site-Specific factor 4 Cancer
IndentIndent42090-1 Collaborative staging site-Specific factor 5 Cancer
IndentIndent42091-9 Collaborative staging site-Specific factor 6 Cancer
IndentIndent42094-3 Derived American Joint Committee on Cancer T Derived
IndentIndent42095-0 Derived American Joint Committee on Cancer T descriptor
IndentIndent21911-3 Primary tumor.other [Class] Cancer
IndentIndent42096-8 Derived American Joint Committee on Cancer N
IndentIndent42097-6 Derived American Joint Committee on Cancer N descriptor
IndentIndent42098-4 Derived American Joint Committee on Cancer M
IndentIndent42099-2 Derived American Joint Committee on Cancer M descriptor
IndentIndent42100-8 Derived American Joint Committee on Cancer stage group
IndentIndent42101-6 Derived SEER summary stage 1977 Cancer
IndentIndent42102-4 Derived SEER summary stage 2000 Cancer
IndentIndent42103-2 Derived American Joint Committee on Cancer conversion method
IndentIndent42104-0 Derived SEER summary stage 1977 conversion method Cancer
IndentIndent42105-7 Derived SEER summary stage 2000 conversion method Cancer
IndentIndent42126-3 Comorbidities and complications 1
IndentIndent42107-3 Comorbidities and complications 2
IndentIndent42108-1 Comorbidities and complications 3
IndentIndent42109-9 Comorbidities and complications 4
IndentIndent42110-7 Comorbidities and complications 5
IndentIndent42111-5 Comorbidities and complications 6
IndentIndent42092-7 Collaborative staging version.first Cancer
IndentIndent42093-5 Collaborative staging version.latest Cancer
IndentIndent42112-3 Comorbidities and complications 7
IndentIndent42113-1 Comorbidities and complications 8
IndentIndent42114-9 Comorbidities and complications 9
IndentIndent42115-6 Comorbidities and complications 10
IndentIndent42116-4 ICD revision comorbidities Cancer
IndentIndent21912-1 Regional lymph nodes.other [Class] Cancer
IndentIndent21913-9 Distant metastases.other [Class] Cancer
IndentIndent21914-7 Stage group.other Cancer
IndentIndent21915-4 Stager.other Cancer
IndentIndent21916-2 Descriptor.other Cancer Narrative
IndentIndent21918-8 Other staging classification Cancer Narrative
Indent46452-9 Treatment-1st course section Set NAACCR v.11
IndentIndent42036-4 Cancer-Directed surgery at this facility 98-02
IndentIndent42037-2 Scope of regional lymph node surgery at this facility 98-02 Cancer
IndentIndent42038-0 Surgery of other regional site(s), distant site(s), or distant lymph node(s) at this facility 98-02 Cancer
IndentIndent21925-3 Date 1st surgery treatment Cancer
IndentIndent39808-1 Date 1st most definitive surgery treatment for Cancer
IndentIndent42117-2 Date of surgical discharge Cancer
IndentIndent21926-1 Date 1st radiation treatment Cancer
IndentIndent42120-6 Date radiation ended Cancer
IndentIndent39809-9 Date 1st systemic treatment Cancer
IndentIndent21927-9 Date 1st chemotherapy treatment Cancer
IndentIndent21928-7 Date 1st hormone treatment Cancer
IndentIndent21929-5 Date 1st immunotherapy treatment Cancer
IndentIndent21930-3 Date 1st other treatment Cancer
IndentIndent21931-1 Date 1st cancer treatment (any).SEERS
IndentIndent21932-9 Date 1st cancer treatment (any).COC
IndentIndent21933-7 Date non cancer directed surgery treatment as part of 1st cancer
IndentIndent21934-5 Surgery site.primary Cancer
IndentIndent21935-2 Surgery scope Cancer
IndentIndent21936-0 Surgery.other regional disease Cancer
IndentIndent21937-8 Surgery regional nodes examined [#] Cancer
IndentIndent21938-6 Surgical approach
IndentIndent21939-4 Surgical margins cancer involvement
IndentIndent21940-2 Surgery reconstruction
IndentIndent21941-0 Reason for no cancer directed surgery
IndentIndent21942-8 Non cancer directed surgery summary
IndentIndent21943-6 Radiation treatment Cancer
IndentIndent21944-4 Lung and leukemia CNS radiation status Cancer
IndentIndent21945-1 Surgery-radiation sequence Cancer
IndentIndent21946-9 Chemotherapy treatment Cancer
IndentIndent21947-7 Hormone treatment Cancer
IndentIndent21948-5 Biological response modifier treatment Cancer
IndentIndent21949-3 Other treatment Cancer
IndentIndent21950-1 Reason for no radiation treatment Cancer
IndentIndent21951-9 Reason for no chemotherapy treatment Cancer
IndentIndent21952-7 Reason for no hormone treatment Cancer
IndentIndent21953-5 Coding system for treatment [Identifier] Cancer
IndentIndent21954-3 Protocol eligibility status Cancer
IndentIndent21955-0 Source of protocol in which patient enrolled Cancer
IndentIndent21956-8 Referred to support services Cancer
IndentIndent21957-6 Method for calculating time interval of first course of treatment
IndentIndent21958-4 Regional radiation treatment Dose cGy
IndentIndent21959-2 Number of radiation treatment {#}
IndentIndent21960-0 Duration first episode Radiation treatment d
IndentIndent21961-8 Organ target(s) First episode Radiation treatment
IndentIndent21962-6 Where performed Radiation treatment
IndentIndent21963-4 Curative intent of treatment Radiation treatment
IndentIndent21964-2 Modality Radiation treatment
IndentIndent42128-9 Boost radiation treatment modality Radiation treatment
IndentIndent42119-8 Boost radiation dose [Energy/mass] cGy
IndentIndent42039-8 Systemic therapy/surgery sequence Cancer
IndentIndent21965-9 Completion status Radiation treatment
IndentIndent21966-7 Regional outcomes of Radiation treatment
IndentIndent21968-3 Surgery Cancer
IndentIndent21969-1 Dx/Stage Procedure
IndentIndent42040-6 Cancer-Directed surgery 98-02 [Anatomy]
IndentIndent42041-4 Scope of regional lymph node surgery 98-02 Cancer
IndentIndent42042-2 Surgery of other regional site(s), distant site(s) or distant lymph nodes 98-02 Cancer
Indent46453-7 Treatment-subsequent and other section Set NAACCR v.11
IndentIndent21970-9 2nd course treatment start date Cancer Rx
IndentIndent21971-7 2nd course treatment Cancer Rx
IndentIndent42043-0 2nd course surgery Cancer Rx
IndentIndent42044-8 2nd course radiation Cancer Rx
IndentIndent42045-5 2nd course chemotherapy Cancer Rx
IndentIndent42046-3 2nd course hormonal therapy Cancer Rx
IndentIndent42047-1 2nd course biological reponse modifier therapy Cancer Rx
IndentIndent42048-9 2nd course other therapy Cancer Rx
IndentIndent21973-3 3rd course treatment Cancer Rx
IndentIndent42049-7 3rd course surgery Cancer Rx
IndentIndent42050-5 3rd course radiation Cancer Rx
IndentIndent42051-3 3rd course chemotherapy Cancer Rx
IndentIndent42052-1 3rd course hormonal therapy Cancer Rx
IndentIndent42053-9 3rd course biological response modifier therapy Cancer Rx
IndentIndent42054-7 3rd course other therapy Cancer Rx
IndentIndent42055-4 4th course Surgery Cancer Rx
IndentIndent42056-2 4th course radiation Cancer Rx
IndentIndent42057-0 4th course chemotherapy Cancer Rx
IndentIndent42058-8 4th course hormonal therapy Cancer Rx
IndentIndent42059-6 4th course biological response modifier therapy Cancer Rx
IndentIndent42060-4 4th course other therapy Cancer Rx
IndentIndent21974-1 Surgery reconstruction Cancer Rx
Indent46440-4 Edit overrides/Conversion history/System admin section Set NAACCR v.11
IndentIndent42067-9 Summary stage and regional lymph nodes positive override flag Cancer case
IndentIndent42068-7 Summary stage and TNM-N override flag Cancer case
IndentIndent42069-5 Summary stage and TNM-M override flag Cancer case
IndentIndent42070-3 Summary stage and distant metastasis 1 override flag Cancer case
IndentIndent42071-1 Accession number and class of case and sequence number override flag Cancer case
IndentIndent42072-9 Hospital sequence number and diagnostic confirmation override flag Cancer case
IndentIndent42073-7 Commission on Cancer (COC) site and type override flag
IndentIndent42074-5 Hospital sequence and site override flag Cancer case
IndentIndent42075-2 Primary site and TNM-stage group override flag Cancer case
IndentIndent21991-5 Age and Site and Morphology override flag Cancer case
IndentIndent21992-3 Sequence numberanddiagnosis confirm override flag Cancer case
IndentIndent21993-1 Site and laterality and sequence number override flag Cancer case
IndentIndent21994-9 Surgery and diagnosis confirm override flag Cancer case
IndentIndent21995-6 Siteandtype override flag Cancer case
IndentIndent21996-4 Histology override flag Cancer case
IndentIndent21997-2 Report source override flag Cancer case
IndentIndent21998-0 Ill defined site override flag Cancer case
IndentIndent21999-8 Leukemia and lymphoma override flag Cancer case
IndentIndent22000-4 Site and behavior override flag Cancer case
IndentIndent22001-2 Site and extent of disease and diagnosis date override flag Cancer case
IndentIndent22002-0 Site and laterality and extent of disease override flag Cancer case
IndentIndent22003-8 Site and laterality and morphology override flag Cancer case
IndentIndent21988-1 Site.ICD-O-1 Cancer
IndentIndent21989-9 Morphology.ICD-O-1 Cancer
IndentIndent42066-1 Histology ICD-O-1 Cancer
IndentIndent42632-0 Grade ICD-O-1 Cancer
IndentIndent21990-7 ICD-O-1 to ICD-O-2 conversion method
IndentIndent22004-6 CRC checksum
IndentIndent22005-3 Date case completed Cancer case
IndentIndent22006-1 Date case last changed Cancer case
IndentIndent22007-9 Date case report exported Cancer case
IndentIndent22011-1 Coding system.current.SEER [Identifier] Cancer registry
IndentIndent22012-9 Coding system.original.SEER [Identifier] Cancer registry
IndentIndent22013-7 Coding system.current. Commission on Cancer (COC) [Identifier] Cancer registry
IndentIndent22014-5 Coding system.original.Commission on Cancer (COC) [Identifier] Cancer registry
IndentIndent22015-2 Follow-up expectation Cancer case
IndentIndent22016-0 SEER record number Cancer case
IndentIndent22017-8 State defined narrative Narrative
IndentIndent22008-7 Date case report received Cancer case
IndentIndent22009-5 Date case report loaded Cancer case
IndentIndent22010-3 Date tumor record available Cancer case
IndentIndent42076-0 ICD-O-2 to ICD-O-3 conversion method
Indent46441-2 Follow-up/Recurrence/Death section Set NAACCR v.11
IndentIndent21975-8 Date last contact
IndentIndent53719-1 Date of death - Canada
IndentIndent31210-8 Vital status NAACCR
Indent46447-9 Special use section Set NAACCR v.11
IndentIndent22017-8 State defined narrative Narrative
Indent46445-3 Patient-confidential section Set NAACCR v.11
IndentIndent22018-6 Military patient number
IndentIndent42077-8 Patient phone number
IndentIndent42127-1 Name of follow-up contact
IndentIndent42078-6 Follow-up contact supplemental information
IndentIndent42130-5 Latitude
IndentIndent42131-3 Longitude
Indent46442-0 Hospital-confidential section Set NAACCR v.11
IndentIndent22023-6 Last follow-up hospital [Identifier] Cancer registry
IndentIndent22024-4 Following registry [Identifier] Cancer registry
IndentIndent22021-0 Institution referred from Cancer registry
IndentIndent22022-8 Institution referred to Cancer registry
Indent46444-6 Other-confidential section Set NAACCR v.11
IndentIndent22025-1 Physician managing [Identifier]
IndentIndent22026-9 Physician follow up [Identifier]
IndentIndent22027-7 Surgeon primary [Identifier]
IndentIndent22028-5 Physician [Identifier]
Indent46449-5 Text-diagnosis section Set NAACCR v.11
IndentIndent22029-3 Physical exam Narrative
IndentIndent22030-1 Xray/ Narrative
IndentIndent22031-9 Scopic exam Narrative
IndentIndent22032-7 Lab tests Narrative
IndentIndent22033-5 Operations (?).total Narrative
IndentIndent22034-3 Pathology report Cancer Narrative
IndentIndent22035-0 Primary site Cancer Narrative
IndentIndent22036-8 Histology Cancer Narrative
IndentIndent22037-6 Staging Cancer Narrative
Indent46451-1 Text-treatment section Set NAACCR v.11
IndentIndent22038-4 Surgery treatment Cancer Narrative
IndentIndent22039-2 Radiation beam treatment Cancer Narrative
IndentIndent22040-0 Radiation other treatment Cancer Narrative
IndentIndent22041-8 Chemotherapy treatment Cancer Narrative
IndentIndent22042-6 Hormone treatment Cancer Narrative
IndentIndent22043-4 Transplant treatment Cancer Narrative
IndentIndent22044-2 Other treatment Cancer Narrative
Indent46450-3 Text-miscellaneous section Set NAACCR v.11
IndentIndent22045-9 Remarks recorded Cancer Narrative
IndentIndent22046-7 Place of 1st Dx [Location] Cancer Narrative

Fully-Specified Name

North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel

Additional Names

Short Name
NAACCR v 11 Pnl

Basic Attributes

First Released
Version 2.21
Last Updated
Version 2.63
Order vs. Observation
Panel Type

Language Variants Get Info

Tag Language Translation
es-MX Spanish (Mexico) Panel de la versión 11 de la Asociación Norteamericana de Registros Centrales del Cáncer, Inc (NAACCR, Inc):-:Punto temporal:^ Paciente:-:
it-IT Italian (Italy) North American Association of Central Cancer Registries, Inc (NAACCR, Inc), panel versione 11:-:Pt:^Paziente:-:
Synonyms: paziente Punto nel tempo (episodio) Registro tumori Set di prescrizione registro tumori
pt-BR Portuguese (Brazil) North American Association of Central Cancer Registries, Inc (NAACCR, Inc) painel:-:Pt:^Paciente:-:
Synonyms: ; NAACCR Pnl; Point in time; Random; Pan; Panl; TUMOR REGISTRY(NAACCR)
ru-RU Russian (Russian Federation) North American Association of Central Cancer Registries, Inc (NAACCR, Inc) версия 11 панель:-:ТчкВрм:^Пациент:-:
Synonyms: Точка во времени;Момент
zh-CN Chinese (China) NAACCR 11 版组套:-:时间点:^患者:-:
Synonyms: NAACCR 11 版组套(组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目);NAACCR v.11 医嘱组;NAACCR 版本 11 医嘱组;癌症登记中心北美协会;North American Association of Central Cancer Registries;NAACCR;North American Association of Central Cancer Registries, Inc;NAACCR, Inc NAACCR 肿瘤登记;癌症登记中心北美协会肿瘤登记;肿瘤注册;肿瘤登记(NAACCR);肿瘤登记(癌症登记中心北美协会);癌症登记中心北美协会;North American Association of Central Cancer Registries;NAACCR 北美癌症登记中心协会 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.肿瘤登记;NAACCR 肿瘤登记组套(组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目);NAACCR 肿瘤登记组套;医嘱组.肿瘤注册;医嘱组.肿瘤登记(NAACCR);医嘱组.肿瘤登记(癌症登记中心北美协会);癌症登记中心北美协会肿瘤登记医嘱组;癌症登记中心北美协会肿瘤登记组套;组套.肿瘤登记;肿瘤注册医嘱组;肿瘤注册组套;肿瘤登记医嘱组;肿瘤登记组套;癌症登记中心北美协会;North American Association of Central Cancer Registries 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 版;版次;变化形式;变体 癌 癌症登记中心北美协会 癌症登记中心北美协会(North American Association of Central Cancer Registries,NAACCR) 组 组合 组合医嘱 组合类 组套

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup$lookup?system=
Questionnaire definition